- Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
-
Park JG
- KMID: 2351029
- Clin Mol Hepatol.
- 2015 Sep;21(3):287-294.
- doi: 10.3350/cmh.2015.21.3.287
BACKGROUND/AIMS: Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
-
Han SH, Park SH, Kim JH, Lee JJ, Kwon SY, Kwon OS, Kim SS, Kim JH, Kim KK, Park YH, Lee JN, Nam E, Bang SM, Cho EK, Shin DB, Lee JH
- KMID: 759855
- Korean J Intern Med.
- 2006 Dec;21(4):225-229.
- doi: 10.3904/kjim.2006.21.4.225
BACKGROUND: Thalidomide has been reported to have antitumor activity for treating metastatic hepatocellular carcinoma (HCC). We evaluated the safety and efficacy of using thalidomide for treating selected patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Practical Effect of Sorafenib Monotherapy on Advanced Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis
-
Jeong SW, Jang JY, Shim KY, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim KH, Kim JH
- KMID: 1712330
- Gut Liver.
- 2013 Nov;7(6):696-703.
BACKGROUND/AIMS: We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. METHODS: In total, 143 consecutive patients with unresectable... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases
-
Yoon KT, Choi JW, Park JY, Ahn SH, Paik YH, Lee KS, Han KH, Chon CY, Kim DY
- KMID: 1381466
- Korean J Hepatol.
- 2008 Sep;14(3):360-370.
- doi: 10.3350/kjhep.2008.14.3.360
BACKGROUND/AIMS: Advanced hepatocellular carcinoma (HCC) with multiple lung metastases has a poor prognosis with no effective treatment having been established. This study evaluated the outcomes of systemic chemotherapy for... -
- CITED
-
- Close
- SHARE
-
- Close
- A Simplified Technique of Percutaneous Hepatic Artery Port-Catheter Insertion for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Invasion
-
Choi SY, Kim AH, Kim KA, Won JY, Lee DY, Lee KH
- KMID: 1119228
- Korean J Radiol.
- 2010 Dec;11(6):648-655.
- doi: 10.3348/kjr.2010.11.6.648
OBJECTIVE: We assessed the outcomes of a simplified technique for the percutaneous placement of a hepatic artery port-catheter system for chemotherapy infusion in advanced hepatocellular carcinoma with portal vein invasion.... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results
-
Kim JS, Park YM, Kim NY, Yun HK, Lee KJ, Kim BH, Park SJ, Yeon JW, Jung G
- KMID: 1015571
- Korean J Hepatol.
- 2011 Jun;17(2):120-129.
- doi: 10.3350/kjhep.2011.17.2.120
BACKGROUND/AIMS: Combination treatment consisting of hepatic arterial infusion chemotherapy with epirubicin and cisplatin (HAIC-EC) and systemic infusion of low-dose 5-fluorouracil (5-FU) are sometimes effective against advanced hepatocellular carcinoma (HCC). However,... -
- CITED
-
- Close
- SHARE
-
- Close
